Healthcare data and intelligence provider Guidepoint Qsight today released its latest report on neurotoxin use in the U.S., Qsight Flash Report: Generational Neurotoxin Use Across the United States.

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today announced a new partnership with The Aesthetic ...

Healthcare data and intelligence provider Guidepoint Qsight has launched its new social media insights platform, Qsight Social Intelligence. Based on proprietary technology developed by Guidepoint ...

The Botox gap between millennials and Gen X is shrinking, according to Qsight data shared with Axios. Why it matters: Botox appointments are becoming about as mainstream as hair appointments.

U.S. aesthetics industry’s measured growth driven by demand for neurotoxins and GLP-1s, signaling shifting patient demand and a maturing industry Guidepoint Qsight, a leading provider of data and ...

WALTHAM, Mass. & SHANGHAI--(BUSINESS WIRE)--(analytica Booth #N2, 2100) PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its new QSight™ ...

More than ever, laboratories analyzing food, cannabis, and environmental samples are faced with evolving challenges with stricter regulations demanding lower detection limits and higher levels of ...

Analysis of U.S. use across generations and states shows a changing balance Qsight estimates $6.4 Billion in total patient spend on neurotoxins in 2024 31% of non-surgical aesthetic spending was on ...

Healthcare data and intelligence provider Guidepoint Qsight has launched its new social media insights platform, Qsight Social Intelligence. Based on proprietary technology developed by Guidepoint ...

Qsight estimates $6.4 Billion in total patient spend on neurotoxins in 2024 31% of non-surgical aesthetic spending was on neurotoxins, an 8% increase over 2023 Millennials closing the gap with Gen X ...